BrightGene Bio-Medical Technology Co., Ltd. (SHA:688166)
45.34
-0.67 (-1.46%)
At close: Feb 13, 2026
54.01% (1Y)
| Market Cap | 19.17B +53.0% |
| Revenue (ttm) | 1.18B -5.0% |
| Net Income | 62.08M -67.0% |
| EPS | 0.15 -66.9% |
| Shares Out | 422.74M |
| PE Ratio | 308.76 |
| Forward PE | n/a |
| Dividend | 0.10 (0.21%) |
| Ex-Dividend Date | Jun 23, 2025 |
| Volume | 4,196,749 |
| Average Volume | 7,115,624 |
| Open | 46.30 |
| Previous Close | 46.01 |
| Day's Range | 45.27 - 46.70 |
| 52-Week Range | 28.84 - 122.59 |
| Beta | 0.21 |
| RSI | 34.66 |
| Earnings Date | Mar 20, 2026 |